Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients
ACS Pharmacology & Translational Science · 08.11.2024 · 7 (11) · 3585-3591
DOI: 10.1021/acsptsci.4c00490 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 07.10.2024. Verfasst von Abdul Salam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histopathology, Institute of Pathology and Diagnostic Medicine, Khyber Medical University, Peshawar 25000, Khyber Pukhtunkhwa, Pakistan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: King Saud University, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Histopathology, Institute of Pathology and Diagnostic Medicine, Khyber Medical University, Peshawar 25000, Khyber Pukhtunkhwa, Pakistan.
- Department of Chemistry, Kohat University of Science and Technology, Kohat 26000, Khyber Pukhtunkhwa, Pakistan.
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Surgery, College of Medicine, King Saud University, P.O. Box 7805, Riyadh 11472, Saudi Arabia.
- Department of Dental Materials, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar 25000, Khyber Pukhtunkhwa, Pakistan.
- Pathology Department, Rehman Medical College, Peshawar 25000, Khyber Pukhtunkhwa, Pakistan.
ORCID-Profile: Umar Nishan, Saifullah Afridi
Förderung
- King Saud University
- National Natural Science Foundation of China
Zitieren
APA
Salam, A., Ali, A., Nishan, U., Khan, N., Ibrahim, M. A., Iqbal, Z., Muhammad, N., Fayyaz, A., Muhammad, F., Mateen, A., Wu, Z., & Afridi, S. (2024). Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients. ACS Pharmacology & Translational Science, 7(11), 3585-3591. https://doi.org/10.1021/acsptsci.4c00490
Vancouver
Salam A, Ali A, Nishan U, Khan N, Ibrahim MA, Iqbal Z, et al. Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients. ACS Pharmacology & Translational Science. 2024;7(11):3585-3591. doi:10.1021/acsptsci.4c00490
BibTeX
@article{Salam2024,
author = {Salam, Abdul and Ali, Asif and Nishan, Umar and Khan, Noaman and Ibrahim, Mohamed A and Iqbal, Zafar and Muhammad, Nawshad and Fayyaz, Anum and Muhammad, Fawad and Mateen, Abdul and Wu, Zhiyuan and Afridi, Saifullah},
title = {Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients},
journal = {ACS Pharmacology & Translational Science},
year = {2024},
volume = {7},
number = {11},
pages = {3585--3591},
doi = {10.1021/acsptsci.4c00490}
}
EUVIMED